Novoseven RT Brand 1mg/vial 1 Vial
$730.00
NovoSeven RT is an injectable medication used to control bleeding episodes and prevent bleeding during surgeries and procedures in adults and children with specific bleeding disorders such as hemophilia.
Description
NovoSeven RT (generic name: recombinant coagulation Factor VII) is an injectable medication used to control bleeding episodes and prevent bleeding during surgeries and procedures in adults and children with specific bleeding disorders. These include hemophilia A or B with inhibitors, congenital Factor VII deficiency, and Glanzmann’s thrombasthenia. It may also be used during the treatment of bleeding and to prevent bleeding in adults with acquired hemophilia who are undergoing surgery and procedures.
Recombinant coagulation factor VIIa (rFVIIa) is a man-made protein designed to mimic the natural clotting factor VIIa in the body, used to help blood clot. It’s particularly important for treating bleeding episodes in individuals with hemophilia who have developed antibodies against traditional clotting factors. rFVIIa is also used in other conditions where traditional hemostatic measures are insufficient.
Dosage
NovoSeven RT is administered by injection. Patients who have been trained may be able to self-administer. Otherwise, it should be done only in a clinical environment under the supervision of a healthcare provider.
Reviews
There are no reviews yet.